5-(N-Difluoromethyl-1,2-dihydropyrid-2-one-4-yl)salicylic acid

ID: ALA578389

Chembl Id: CHEMBL578389

PubChem CID: 45487106

Max Phase: Preclinical

Molecular Formula: C13H9F2NO4

Molecular Weight: 281.21

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1cc(-c2ccn(C(F)F)c(=O)c2)ccc1O

Standard InChI:  InChI=1S/C13H9F2NO4/c14-13(15)16-4-3-8(6-11(16)18)7-1-2-10(17)9(5-7)12(19)20/h1-6,13,17H,(H,19,20)

Standard InChI Key:  KILQIWKOCXSELP-UHFFFAOYSA-N

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
5-lipoxygenase (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 281.21Molecular Weight (Monoisotopic): 281.0500AlogP: 2.31#Rotatable Bonds: 3
Polar Surface Area: 79.53Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 2.70CX Basic pKa: CX LogP: 2.69CX LogD: -0.81
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.90Np Likeness Score: -0.47

References

1. Chowdhury MA, Abdellatif KR, Dong Y, Das D, Yu G, Velázquez CA, Suresh MR, Knaus EE..  (2009)  Synthesis and biological evaluation of salicylic acid and N-acetyl-2-carboxybenzenesulfonamide regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.,  19  (24): [PMID:19884005] [10.1016/j.bmcl.2009.10.083]

Source